Platform Technology | Novel Therapies | Advanced Digital Solutions

 LIVE ONLINE 23 September 2021

PharmaTech Integrates Leadership Team and Advisory Board

The Executive Advisory Board is ideally placed to provide expert insight into the critical issues and challenges facing the PharmaTech industry today. Together they bring a wealth of first-hand experience and knowledge, sharing our determination to encourage further collaboration amongst key stakeholders shaping the future of the PharmaTech industry.

We have assembled a group of renowned experts from across the sector including manufacturing, academia, technology and supply chain organisations. Kindly contact Christopher Watt or Samuel Thangiah if you would like to be considered for the PharmaTech Advisory Board.

DAVE TUDOR

Managing Director
Medicines Manufacturing Innovation Centre

CPI

CLIVE BADMAN

Executive Director

University of Strathclyde

Christopher Watts

CHRISTIAN JONES

Chief Commercial Officer

Nanoform

MASSIMO BRESCIANI

Industry Director, EPSRC Future Manufacturing Research Hub

CMAC

Christopher Watts

STEVE BARR

Vice President Business Development

SK biotek

JON-PAUL SHERLOCK

 Global Technology Strategy Director, MS&T

AstraZeneca

ANDREW MATTHEWS

Head of Pharma & Life Sciences

Siemens

MARK TALFORD

Deputy Challenge Director

Medicines Manufacturing

Christopher Watts

ROSS MACRAE

Head of Drug Product Manufacturing

Pfizer

Christopher Watts

JESKE SMINK

Head of Drug Substance

Silence Therapeutics

Christopher Watts

ANDREW HENDERSON

Team Leader – High Value Manufacturing Team

Scottish Enterprise

Christopher Watts

ANDY ROSS

Vice President, Head of Internal Biopharm & Steriles Manufacturing

GSK

Platform Technology | Novel Therapies | Advanced Digital Solutions

 LIVE ONLINE 23 September 2021